|1.||Sokolović, Marijana: 1 article (06/2004)|
|2.||Gudan, Andrea: 1 article (06/2004)|
|3.||Severin, Kresimir: 1 article (06/2004)|
|4.||Konjević, Dean: 1 article (06/2004)|
|5.||Lojkić, Ivana: 1 article (06/2004)|
|6.||Srebocan, Emil: 1 article (06/2004)|
|7.||Hamilton, P B: 1 article (06/2000)|
|8.||Brake, J: 1 article (06/2000)|
|9.||Kittrell, R S: 1 article (06/2000)|
02/01/1984 - "Anguidine: a broad phase II study of the Southeastern Cancer Study Group."
02/01/1984 - "Anguidine, a phase II agent, was used to treat 276 patients with solid tumors. "
12/01/1987 - "Dietary treatment of animals with extracts of Fusaria cultures or with the trichothecene diacetoxyscirpenol (DS) caused esophageal hyperplasia but not cancer. "
01/01/1987 - "Effect of the trichothecene mycotoxin diacetoxyscirpenol on nitrosamine-induced oesophageal cancer and on relevant enzymes in oesophagus and liver."
01/01/1986 - "Thus, anguidine enhances cis-platinum-induced DNA cross-linking and subsequent cytotoxicity in human brain tumor cells, and may be clinically useful in combination with cis-platinum in those tumors."
|2.||Colonic Neoplasms (Colon Cancer)
10/01/1978 - "Because of disappointing results in clinical trials, we analyzed the lethal and cytokinetic effects of anguidine on cultured human colon cancer cells. "
10/01/1978 - "Tumoricidal activity of anguidine in a cultured human colon cancer line is poor and requires prolonged exposure. "
10/01/1978 - "Anguidine is a fungal metabolite with antitumor activity in a murine colon cancer model. "
10/01/1978 - "Lethal and cytokinetic effects of anguidine on a human colon cancer cell line."
02/01/1982 - "Antitumor activity of anguidine in patients with colon cancer may be similar to that of 5-FU, but nonhematologic toxicity is substantial."
|3.||Central Nervous System Neoplasms
|4.||Colorectal Neoplasms (Colorectal Cancer)
|5.||Sarcoma (Soft Tissue Sarcoma)
|3.||T-2 Toxin (T 2 Toxin)
|4.||amsonic acid (DAS)
|1.||Drug Therapy (Chemotherapy)